About aol
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: aol@amegroups.com -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Case Report
Annals of Lymphoma
2024;
8:
5
(30 July 2024)
Case Report
Annals of Lymphoma
2024;
8:
4
(30 June 2024)
Original Article
Annals of Lymphoma
2024;
8:
3
(30 May 2024)
Case Report
Annals of Lymphoma
2024;
8:
2
(30 May 2024)
Review Article
Annals of Lymphoma
2024;
8:
1
(30 May 2024)
Case Report
Annals of Lymphoma
2023;
7:
2
(30 March 2023)
Original Article
Annals of Lymphoma
2023;
7:
1
(28 February 2023)
Review Article
Annals of Lymphoma
2022;
6:
13
(30 December 2022)
Review Article
Annals of Lymphoma
2022;
6:
12
(30 December 2022)
Review Article
Annals of Lymphoma
2022;
6:
11
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
10
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
9
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
8
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
6
(30 June 2022)
Review Article
Annals of Lymphoma
2022;
6:
5
(30 June 2022)
Editorial
Annals of Lymphoma
2022;
6:
4
(30 June 2022)
Case Report
Annals of Lymphoma
2022;
6:
3
(30 March 2022)
Case Report
Annals of Lymphoma
2022;
6:
2
(30 March 2022)
Review Article
Annals of Lymphoma
2022;
6:
1
(30 March 2022)
Currently no content available!